Repligen | RGEN - Stock


Repligen reported $160.32M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Agilent USD 1.03B 11M Sep/2025
Align Technology USD 228.16M 15.59M Sep/2025
Bio Techne USD 205.45M 2.26M Dec/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Bruker USD 1.2B 21.7M Sep/2025
Charles River Laboratories USD 302.55M 23M Sep/2025
Danaher USD 2.49B 185M Dec/2025
Dentsply International USD 686M 11M Sep/2025
Exact Sciences USD 164.78M 6.72M Sep/2025
General Electric Aerospace USD 11.87B 201M Dec/2025
Henry Schein USD 1.91B 4M Sep/2025
Illumina USD 590M 15M Sep/2025
Mettler Toledo International USD 401.81M 13.73M Sep/2025
Myriad Genetics USD 31.6M 2.9M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Repligen USD 160.32M 4.46M Sep/2025
Revvity USD 379.92M 8.55M Sep/2025
Standard Biotools USD 25.42M 1.25M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Waters USD 572.94M 32.19M Sep/2025
West Pharmaceutical Services USD 438M 16.9M Sep/2025